Physiological Basis
Erectile function depends on adequate arterial inflow to the corpus cavernosum — specifically, perfusion through the bilateral cavernosal arteries (branches of the internal pudendal arteries) sufficient to generate and sustain intracavernosal pressure above systemic diastolic blood pressure. In arteriogenic erectile dysfunction caused by focal atherosclerotic occlusion, thrombosis, or traumatic disruption of the pudendal or cavernosal arterial supply, perfusion pressure downstream of the obstruction is insufficient to achieve or maintain a rigid erection. Pharmacological amplification of the nitric oxide-cGMP pathway (via PDE5 inhibitors) or angiogenic stimulation (via Li-ESWT or regenerative injection) cannot compensate for a haemodynamically significant proximal arterial occlusion. The only direct corrective intervention in this setting is restoration of arterial continuity through bypass surgery.
Microsurgical penile revascularisation creates a new arterial conduit bypassing the obstructed or disrupted penile arterial supply by anastomosing the inferior epigastric artery — a well-vascularised, accessible branch of the external iliac artery running in the posterior rectus sheath of the lower abdominal wall — to either the dorsal penile artery or the cavernosal artery directly. This new conduit delivers oxygenated blood under systemic arterial pressure to the penile circulation distal to the obstruction, restoring baseline haemodynamic capacity for spontaneous erection. The procedure is conceptually analogous to coronary artery bypass grafting — using an autologous artery to bypass a focal occlusion — but performed under operating microscope magnification on vessels 1 to 3 mm in diameter.
This is the only andrological procedure classified as potentially curative for arteriogenic erectile dysfunction, as distinct from all other surgical options for ED (penile prosthesis implantation), which are prosthetic rather than restorative. The strict patient selection criteria for revascularisation — young age, focal vascular disease without systemic atherosclerosis, no significant venogenic component — reflect the dependence of graft patency and functional outcome on the quality of the recipient arterial bed and the absence of competing pathology.
The Treatment Protocol
The procedure is performed under general anaesthesia. An infraumbilical midline or paramedian incision provides access to the inferior epigastric artery within the posterior rectus sheath. A segment of 8 to 10 cm of the inferior epigastric artery is harvested, preserving its branches, and prepared for anastomosis. A separate incision on the dorsal penile shaft exposes the dorsal penile artery or, if a cavernosal artery anastomosis is planned, the lateral penile shaft is opened to access the cavernosal artery within Buck's fascia. Under operating microscope magnification (typically ×10 to ×16), a microsurgical end-to-side or end-to-end anastomosis is fashioned between the harvested inferior epigastric artery and the target penile artery using 8-0 to 10-0 nylon suture — suture finer than human hair. Patency is confirmed intraoperatively with Doppler assessment and visual inspection of pulsatile flow. Meticulous haemostasis is achieved at both surgical sites, and wounds are closed in two layers.
The patient is hospitalised for 1 to 2 days post-operatively for haemodynamic monitoring and wound assessment. Post-operative instructions include strict avoidance of any pressure or compression to the penile shaft (supportive underwear, no cycling) for 6 to 8 weeks, tobacco abstinence (mandatory — nicotine-mediated vasoconstriction directly threatens graft patency), and aspirin therapy for antiplatelet graft protection as directed by the surgeon. Follow-up penile Doppler ultrasound at 3 and 6 months post-operatively confirms graft patency and quantifies haemodynamic improvement.
Who is a Candidate
Microsurgical penile revascularisation has a narrow and well-defined candidacy profile. The procedure is appropriate for young men — generally under 55 years of age — with confirmed arteriogenic erectile dysfunction on penile duplex Doppler ultrasound (bilateral PSV below 25 cm/s), in whom a focal identifiable vascular aetiology can be demonstrated: perineal or pelvic trauma (saddle injury, cycling-related pudendal artery compression, pelvic fracture), post-traumatic arterial thrombosis, or focal atherosclerotic occlusion in the absence of systemic diffuse atherosclerotic disease. Pelvic arteriography or MR angiography of the pudendal circulation is performed pre-operatively to confirm the site and extent of the occlusion and to verify adequate distal runoff in the target penile vessels. An absent or negligible venogenic component is required — men with concurrent corporal veno-occlusive dysfunction (elevated EDV on Doppler) have a significantly diminished outcome from revascularisation alone.
Contraindications include diffuse systemic atherosclerosis affecting the downstream penile arterial bed (which prevents effective run-off from the bypass), active tobacco use (absolute — must be abstinent for a minimum of 3 to 6 months pre-operatively), diabetes mellitus with microvascular disease compromising distal vessel quality, age above 55 to 60 years in most series (where systemic vascular disease prevalence reduces candidate suitability), and significant venogenic dysfunction as the primary or co-primary aetiology. Men with normal or only mildly reduced PSV on Doppler are unlikely to benefit from revascularisation regardless of age.
Expected Outcomes and Timeline
In properly selected patients — young men with focal arteriogenic disease, absent systemic atherosclerosis, no significant venogenic component, and tobacco abstinence — published series report durable erectile function improvement sufficient for intercourse without pharmacological support in 50 to 70% of patients at 3 to 5-year follow-up. These outcomes represent the strongest long-term functional success rates of any intervention for arteriogenic ED. Haemodynamic improvement, as measured by increase in PSV on post-operative Doppler, typically precedes functional erectile improvement by several months as cavernosal smooth muscle and neural elements adapt to restored perfusion pressure. Full functional assessment is deferred until 6 months post-operatively. In patients achieving graft patency and adequate haemodynamic improvement, the functional benefit is durable — graft patency, once established at 3 months, is generally sustained long-term in the absence of new atherosclerotic disease or trauma.
Safety Profile and Risks
General anaesthesia risks are as applicable to any procedure of this duration. Surgical wound complications at either the abdominal or penile incision site — haematoma, seroma, superficial wound dehiscence — are uncommon with meticulous technique. Penile oedema following dorsal dissection and bypass is expected and resolves over 4 to 8 weeks. Graft failure (anastomotic thrombosis) is the primary procedure-specific risk and is minimised by superior microsurgical technique, appropriate vessel preparation, antiplatelet therapy, and mandatory tobacco abstinence. Glans hyperaemia — engorgement and hypersensitivity of the glans penis from retrograde high-pressure flow transmitted through the new anastomosis — occurs in a subset of patients and ranges from mildly bothersome to requiring a secondary venous outflow procedure if significant.
Cost and Accessibility
Microsurgical penile revascularisation carries the highest cost of any non-implant andrological procedure, reflecting extended operating time (3 to 5 hours), operating microscope use, the subspecialty microsurgical expertise required, and hospital facility fees. Most cases are cash-pay; however, some commercial insurers provide coverage for arterial bypass surgery when a clear traumatic aetiology (pelvic fracture, perineal injury) is documented and the clinical indication is well-supported in the medical record. Pre-authorisation requires detailed documentation of the diagnostic workup, including Doppler and arteriographic findings.
Selecting a Qualified Provider
The procedural subspecialty requirements for microsurgical penile revascularisation are among the most stringent in andrology. The operating surgeon must hold ABU board certification, have completed formal microsurgical fellowship training (andrology or reproductive microsurgery), and maintain an active case volume sufficient to preserve operative proficiency at the microscope. SMSNA membership and active engagement with the sexual medicine and microsurgical andrology literature are markers of appropriate clinical orientation. Patients should request specific information about the surgeon's case volume for penile revascularisation, their post-operative Doppler patency data, and their published or documented functional outcomes before proceeding.